OtoSim Inc., a MaRS Innovation spin-of company, was featured along with MaRS Innovation in the Autumn 2012 edition of Health Research & Innovation magazine. The article by Tim Wilson is…
GEN Magazine (Genetic Engineering and Biotechnology News) featured the microfluidics research of Dr. Aaron Wheeler on November 15, 2012.
Wheeler, Canada Research Chair of Bioanalytical Chemistry and an associate professor at the University of Toronto, has made an invention disclosure to MaRS Innovation; Kapplex is the start-up company created to commercialize his research.
MaRS Innovation's President and CEO, Raphael Hofstein, has published an editorial outlining the challenges facing entrepreneurs seeking to bring new healthcare innovations to market for the National Post's Medical Devices…
MaRS Innovation and the University Health Network‘s Toronto Rehabilitation Institute have collaborated to bring a new technology to market that accurately diagnoses sleep apnea at the patient’s home.
Sleep apnea is a medical disorder that is gaining increasing recognition as a major health issue. It is estimated that six to eight per cent of the world’s population suffer from the disease, but 85 per cent are undiagnosed.
Undiagnosed sleep apnea is estimated to cause $3.4 billion in additional medical costs in the US.
Schwartz Reisman Innovation Campus, West Tower
108 College Street, Suite 530
Toronto, ON M5G 0C6
info@tiap.ca